Systematic review of clinical practice guidelines in the diagnosis and management of thyroid nodules and cancer

详细信息    查看全文

• 作者：Tsai-Wei Huang (1)
  Jun-Hung Lai (1) (2)
  Mei-Yi Wu (3) (4)
  Shiah-Lian Chen (1)
  Chih-Hsiung Wu (5) (6)
  Ka-Wai Tam (4) (5) (6) (7) (8) (9)
  
• 关键词：Clinical practice guidelines ; Thyroid cancer ; Thyroid nodule ; Systematic review
• 刊名：BMC Medicine
• 出版年：2013
• 出版时间：December 2013
• 年：2013
• 卷：11
• 期：1
• 全文大小：201KB
• 参考文献：1. Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F, Evans JG, Young E, Bird T, Smith PA: The spectrum of thyroid disease in a community: the Whickham survey. / Clin Endocrinol (Oxf) 1977, 7:481-93. CrossRef
  2. Vander JB, Gaston EA, Dawber TR: The significance of nontoxic thyroid nodules. Final report of a 15-year study of the incidence of thyroid malignancy. / Ann Intern Med 1968, 69:537-40. CrossRef
  3. Hegedüs L: Clinical practice. The thyroid nodule. / N Engl J Med 2004, 351:1764-771. CrossRef
  4. Mandel SJ: A 64-year-old woman with a thyroid nodule. / JAMA 2004, 292:2632-642. CrossRef
  5. Coleman MP, Estève J, Damiecki P, Arslan A, Renard H: Trends in cancer incidence and mortality. / IARC Sci Publ 1993, 121:1-06.
  6. Sherman SI: Thyroid carcinoma. / Lancet 2003, 361:501-11. CrossRef
  7. Grilli R, Magrini N, Penna A, Mura G, Liberati A: Practice guidelines developed by specialty societies: the need for a critical appraisal. / Lancet 2000, 355:103-06. CrossRef
  8. Graham ID, Harrison MB: Evaluation and adaptation of clinical practice guidelines. / Evid Based Nurs 2005, 8:68-2. CrossRef
  9. Oxman AD, Glasziou P, Williams JW Jr: What should clinicians do when faced with conflicting recommendations? / BMJ 2008, 337:a2530. CrossRef
  10. The AGREE Research Trust: Appraisal of Guidelines for Research and Evaluation II Instrument. In Edited by: Brouwers MC. 2009.
  11. Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, Fervers B, Graham ID, Grimshaw J, Hanna S, Littlejohns P, Makarski J, Zitzelsberger L: for the AGREE Next Steps Consortium. AGREE II: Advancing guideline development, reporting and evaluation in healthcare. / Can Med Assoc J 2010, 182:839-42. CrossRef
  12. Qaseem A, Snow V, Shekelle P, Hopkins R Jr, Owens DK: Screening for HIV in health care settings: a guidance statement from the American College of Physicians and HIV Medicine Association. / Ann Intern Med 2009, 150:125-31. CrossRef
  13. Sinuff T, Patel RV, Adhikari NK, Meade MO, Schünemann HJ, Cook DJ: Quality of professional society guidelines and consensus conference statements in critical care. / Crit Care Med 2008, 36:1049-058. CrossRef
  14. Gharib H, Papini E, Paschke R, Duick DS, Valcavi R, Hegedüs L, Vitti P: American association of clinical endocrinologists, associazione Medici endocrinologi, and European thyroid association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. / J Endocrinol Invest 2010, 33:1-0.
  15. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM, American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer: Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. / Thyroid 2009, 19:1167-214. CrossRef
  16. The British Thyroid Association and the Royal College of Physicians: / Guidelines for the Management of Thyroid Cancer. 2nd edition. 2007. Available: http://www.british-thyroid-association.org
  17. Pacini F, Castagna MG, Brilli L, Pentheroudakis G, ESMO Guidelines Working Group: Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. / Ann Oncol 2012, 23:vii110-19. CrossRef
  18. Dralle H, Musholt TJ, Schabram J, Steinmüller T, Frilling A, Simon D, Goretzki PE, Niederle B, Scheuba C, Clerici T, Hermann M, Ku?mann J, Lorenz K, Nies C, Schabram P, Trupka A, Zielke A, Karges W, Luster M, Schmid KW, Vordermark D, Schmoll HJ, Mühlenberg R, Schober O, Rimmele H, Machens A, German Societies of General and Visceral Surgery; Endocrinology; Nuclear Medicine; Pathology; Radiooncology; Oncological Hematology; and the German Thyroid Cancer Patient Support Organization Ohne Schilddrüse leben e.V: German association of endocrine surgeons practice guideline for the surgical management of malignant thyroid tumors. / Langenbecks Arch Surg 2013, 398:347-75. CrossRef
  19. Comprehensive Cancer Centre, The Netherlands: Thyroid Carcinoma (English version). National Evidence-Based Guideline. Version:1.0. 2007.
  20. Pitoia F, Ward L, Wohllk N, Friguglietti C, Tomimori E, Gauna A, Camargo R, Vaisman M, Harach R, Munizaga F, Corigliano S, Pretell E, Niepomniszcze H: Recommendations for the Latin American Thyroid Society on diagnosis and management of differentiated thyroid cancer. / Arq Bras Endocrinol Metabol 2009, 53:884-87. CrossRef
  21. National Cancer Comprehensive Network (NCCN Guidelines): Thyroid carcinoma. Version 2. 2013.
  22. Regional Thyroid Cancer Group: Northern Cancer Network guidelines for management of thyroid cancer. / Clin Oncol (R Coll Radiol) 2000, 12:373-91.
  23. Martínez Trufero J, Capdevilla J, Cruz JJ, Isla D: SEOM clinical guidelines for the treatment of thyroid cancer. / Clin Transl Oncol 2011, 13:574-79. CrossRef
  24. Shekelle P, Eccles MP, Grimshaw JM, Woolf SH: When should clinical guidelines be updated? / BMJ 2001, 323:155-57. CrossRef
  25. Shekelle PG, Ortiz E, Rhodes S, Morton SC, Eccles MP, Grimshaw JM, Woolf SH: Validity of the agency for healthcare research and quality clinical practice guidelines: how quickly do guidelines become outdated? / JAMA 2001, 286:1461-467. CrossRef
  26. The ADAPTE Collaboration: / The ADAPTE Process: Resource Toolkit for Guideline Adaptation. 2nd edition. 2009. Available: http://www.adapte.org
  27. Al-Ansary LA, Tricco AC, Adi Y, Bawazeer G, Perrier L, Al-Ghonaim M, AlYousefi N, Tashkandi M, Straus SE: A systematic review of recent clinical practice guidelines on the diagnosis, assessment and management of hypertension. / PLoS One 2013, 8:e53744. CrossRef
  28. Campbell F, Dickinson HO, Cook JV, Beyer FR, Eccles M, Mason JM: Methods underpinning national clinical guidelines for hypertension: describing the evidence shortfall. / BMC Health Serv Res 2006, 6:47. CrossRef
  29. Bilimoria KY, Bentrem DJ, Ko CY, Stewart AK, Winchester DP, Talamonti MS, Sturgeon C: Extent of surgery affects survival for papillary thyroid cancer. / Ann Surg 2007, 246:375-81. CrossRef
  30. Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, Fervers B, Graham ID, Grimshaw J, Hanna SE, Littlejohns P, Makarski J, Zitzelsberger L: The Global Rating Scale complements the AGREE II in advancing the quality of practice guidelines. / J Clin Epidemiol 2012, 65:526-34. CrossRef
  31. The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1741-7015/11/191/prepub
  
• 作者单位：Tsai-Wei Huang (1)
  Jun-Hung Lai (1) (2)
  Mei-Yi Wu (3) (4)
  Shiah-Lian Chen (1)
  Chih-Hsiung Wu (5) (6)
  Ka-Wai Tam (4) (5) (6) (7) (8) (9)
  
  1. Department of Nursing, College of Medicine and Nursing, Hung Kuang University, Taichung, Taiwan
  2. Department of Internal Medicine, Erlin Branch of Changhua Christian Hospital, Taichung, Taiwan
  3. Division of Nephrology, Department of Internal Medicine, Taipei Medical University - Shuang Ho Hospital, Taipei, Taiwan
  4. Center for Evidence-based Health Care, Taipei Medical University - Shuang Ho Hospital, Taipei, Taiwan
  5. Department of Surgery, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
  6. Division of General Surgery, Department of Surgery, Taipei Medical University - Shuang Ho Hospital, Taipei, Taiwan
  7. Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
  8. Center for Evidence-based Medicine, Taipei Medical University, Taipei, Taiwan
  9. Evidence-based Medicine Center, Taipei Medical University Hospital, 252 Wu-Hsing Street, Taipei, 11031, Taiwan
  

文摘

Background Given the uncertainties regarding thyroid nodule assessment and management, physicians require systematically and transparently developed recommendations. This systematic review assesses the quality and consistency of the recommendations of international clinical practice guidelines (CPGs) for the diagnosis and management of thyroid nodules and cancer to assist physicians in making appropriate recommendations. Methods The CPGs on the management of thyroid nodules and cancer published before June 2013 were retrieved. All the reviewed guidelines were in English. Four reviewers independently assessed the rigor of guideline development by using the Appraisal of Guidelines Research and Evaluation II (AGREE-II) instrument, and their reported evidence was evaluated. Results Ten eligible guidelines were included: nine had been developed by professional organizations, and the remaining guideline was endorsed by an independent regional body. Three guidelines achieved a score of greater than 50% in all six AGREE-II domains. Guidelines scored highest on the measurement of ‘scope and purpose-(?1.1% for eight CPGs) and lowest on the measurement of ‘applicability-(?8.5% for five CPGs). The overall quality ranged from 3.0 to 6.25 on a seven-point scale on the AGREE-II tool. Most CPG recommendations on the management of thyroid cancer were relatively consistent. Guidelines varied regarding the indication of fine-needle aspiration for thyroid nodules, as well as in their suggestions for postoperative radioiodine ablation. Conclusions Our analysis showed that the current CPGs varied in methodological quality. More effort is needed to improve the quality of recommendations on the diagnosis and management of thyroid nodules and cancer.